Europe Point of Care (PoC) Molecular Diagnostics Market 2020-2030

Europe PoC molecular diagnostics market accounted for $405.1 million in 2019 and will grow by 13.3% annually over 2020-2030

Europe PoC molecular diagnostics market accounted for $405.1 million in 2019 and will grow by 13.3% annually over 2020-2030 owing to the rising adoption of personalized medicine and PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic. Highlighted with 37 tables and 53 figures, this 124-page report “Europe Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Kits & Assays • Analyzers & Instruments • Software & Services

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Polymerase Chain Reaction (PCR) • Real-Time PCR (rt-PCR) • Digital PCR (d-PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) Genetic Sequencing-based Technology Microarray-based Technology Other Technologies Based on Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Infectious Disease • Respiratory Infections • Hospital Acquired Infections • Sexually Transmitted Infections Gastrointestinal Infections Oncology Hepatitis Prenatal/Neonatal Testing Other Applications Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Hospitals • Clinics & Diagnostic Centers • Research and Academic Institutes • Other End Users

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Europe PoC molecular diagnostics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Abacus Diagnostica Oy Abbott Laboratories Alere Inc. Biocartis Group NV Biomerieux SA Bio-Rad Laboratories Inc Danaher Corporation DiaSorin S.p.A DxNA LLC. F. Hoffmann-La Roche Ltd. Hologic, Inc. Luminex Corporation Meridian Bioscience Inc. Mesa Biotech Inc. QIAGEN N.V. QuantuMDx Group Ltd. Quidel Corporation Spartan Biosciences Inc. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

Table of Contents

  • 1 Introduction 7
  • 1.1 Industry Definition and Research Scope 7
  • 1.1.1 Industry Definition 7
  • 1.1.2 Research Scope 8
  • 1.2 Research Methodology 11
  • 1.2.1 Overview of Market Research Methodology 11
  • 1.2.2 Market Assumption 12
  • 1.2.3 Secondary Data 12
  • 1.2.4 Primary Data 12
  • 1.2.5 Data Filtration and Model Design 14
  • 1.2.6 Market Size/Share Estimation 15
  • 1.2.7 Research Limitations 16
  • 1.3 Executive Summary 17
  • 2 Market Overview and Dynamics 20
  • 2.1 Market Size and Forecast 20
  • 2.1.1 Impact of COVID-19 on World Economy 21
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.2 Major Growth Drivers 26
  • 2.3 Market Restraints and Challenges 31
  • 2.4 Emerging Opportunities and Market Trends 34
  • 2.5 Porter’s Fiver Forces Analysis 38
  • 3 Segmentation of Europe Market by Product 43
  • 3.1 Market Overview by Product 43
  • 3.2 Kits & Assays 45
  • 3.3 Analyzers & Instruments 46
  • 3.4 Software & Services 47
  • 4 Segmentation of Europe Market by Technology 48
  • 4.1 Market Overview by Technology 48
  • 4.2 Polymerase Chain Reaction (PCR) 50
  • 4.2.1 Real-Time PCR (rt-PCR) 51
  • 4.2.2 Digital PCR (d-PCR) 52
  • 4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 53
  • 4.4 Genetic Sequencing-based Technology 54
  • 4.5 Microarray-based Technology 55
  • 4.6 Other Technologies 56
  • 5 Segmentation of Europe Market by Application 57
  • 5.1 Market Overview by Application 57
  • 5.2 Infectious Disease 59
  • 5.2.1 Respiratory Infections 61
  • 5.2.2 Hospital Acquired Infections 62
  • 5.2.3 Sexually Transmitted Infections 63
  • 5.3 Gastrointestinal Infections 64
  • 5.4 Oncology 65
  • 5.5 Hepatitis 66
  • 5.6 Prenatal/Neonatal Testing 67
  • 5.7 Other Applications 68
  • 6 Segmentation of Europe Market by End User 69
  • 6.1 Market Overview by End User 69
  • 6.2 Hospitals 71
  • 6.3 Clinics & Diagnostic Centers 72
  • 6.4 Research and Academic Institutes 73
  • 6.5 Other End Users 74
  • 7 European Market 2019-2030 by Country 76
  • 7.1 Overview of European Market 76
  • 7.2 Germany 79
  • 7.3 UK 81
  • 7.4 France 83
  • 7.5 Spain 85
  • 7.6 Italy 87
  • 7.7 Russia 89
  • 7.8 Rest of European Market 91
  • 8 Competitive Landscape 93
  • 8.1 Overview of Key Vendors 93
  • 8.2 New Product Launch, Partnership, Investment, and M&A 97
  • 8.3 Company Profiles 98
  • Abacus Diagnostica Oy 98
  • Abbott Laboratories 100
  • Alere Inc. 101
  • Biocartis Group NV 102
  • Biomerieux SA 103
  • Bio-Rad Laboratories Inc 104
  • Danaher Corporation 105
  • DiaSorin S.p.A 106
  • DxNA LLC. 107
  • F. Hoffmann-La Roche Ltd. 108
  • Hologic, Inc. 109
  • Luminex Corporation 110
  • Meridian Bioscience Inc. 111
  • Mesa Biotech Inc. 112
  • QIAGEN N.V. 113
  • QuantuMDx Group Ltd. 114
  • Quidel Corporation 115
  • Spartan Biosciences Inc. 116
  • Thermo Fisher Scientific 117
  • 9 Investing in Europe Market: Risk Assessment and Management 118
  • 9.1 Risk Evaluation of Europe Market 118
  • 9.2 Critical Success Factors (CSFs) 121
  • Related Reports and Products 124

Table 1. Snapshot of Europe Point of Care (PoC) Molecular Diagnostics Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Market Opportunities in Europe Point of Care (PoC) Molecular Diagnostics Market 34
Table 4. Europe Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 43
Table 5. Europe Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 48
Table 6. Europe Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn 50
Table 7. Europe Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 57
Table 8. Europe Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn 60
Table 9. Europe Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn 69
Table 10. Europe Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 78
Table 11. Germany Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 80
Table 12. Germany Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 80
Table 13. Germany Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 80
Table 14. UK Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 82
Table 15. UK Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 82
Table 16. UK Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 82
Table 17. France Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 84
Table 18. France Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 84
Table 19. France Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 84
Table 20. Spain Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 86
Table 21. Spain Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 86
Table 22. Spain Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 86
Table 23. Italy Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 88
Table 24. Italy Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 88
Table 25. Italy Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 88
Table 26. Russia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 90
Table 27. Russia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 90
Table 28. Russia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 90
Table 29. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe by Country, 2019-2030, $ mn 92
Table 30. Breakdown of Europe Market by Key Vendor, 2019, % 95
Table 31. Abacus Diagnostica Oy: Company Snapshot 98
Table 32. Abacus Diagnostica Oy: Business Segmentation 98
Table 33. Abacus Diagnostica Oy: Product Portfolio 99
Table 34. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn 99
Table 35. Abacus Diagnostica Oy: Recent Developments 99
Table 36. Risk Evaluation for Investing in Europe Market, 2019-2030 119
Table 37. Critical Success Factors and Key Takeaways 122

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Europe Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Europe Point of Care (PoC) Molecular Diagnostics Market 26
Figure 8. World Number of Deaths by Cause in 2017 29
Figure 9. World Number of Deaths from Cancers in 2017 30
Figure 10. Primary Restraints and Impact Factors of Europe Point of Care (PoC) Molecular Diagnostics Market 31
Figure 11. Investment Opportunity Analysis 35
Figure 12. Porter’s Fiver Forces Analysis of Europe Point of Care (PoC) Molecular Diagnostics Market 38
Figure 13. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue 43
Figure 14. Europe Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 44
Figure 15. Europe Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn 45
Figure 16. Europe Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn 46
Figure 17. Europe Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn 47
Figure 18. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue 48
Figure 19. Europe Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 20. Europe Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 21. Europe Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn 51
Figure 22. Europe Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn 52
Figure 23. Europe Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn 53
Figure 24. Europe Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn 54
Figure 25. Europe Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn 55
Figure 26. Europe Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn 56
Figure 27. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 28. Europe Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 29. Europe Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn 59
Figure 30. Europe Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn 61
Figure 31. Europe Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn 62
Figure 32. Europe Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn 63
Figure 33. Europe Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn 64
Figure 34. Europe Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn 65
Figure 35. Europe Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn 66
Figure 36. Europe Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn 67
Figure 37. Europe Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn 68
Figure 38. Breakdown of Europe Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue 69
Figure 39. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 70
Figure 40. Europe Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn 71
Figure 41. Europe Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn 72
Figure 42. Europe Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn 73
Figure 43. Europe Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn 74
Figure 44. Breakdown of European Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 77
Figure 45. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 78
Figure 46. Point of Care (PoC) Molecular Diagnostics Market in Germany, 2019-2030, $ mn 79
Figure 47. Point of Care (PoC) Molecular Diagnostics Market in UK, 2019-2030, $ mn 81
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in France, 2019-2030, $ mn 83
Figure 49. Point of Care (PoC) Molecular Diagnostics Market in Spain, 2019-2030, $ mn 85
Figure 50. Point of Care (PoC) Molecular Diagnostics Market in Italy, 2019-2030, $ mn 87
Figure 51. Point of Care (PoC) Molecular Diagnostics Market in Russia, 2019-2030, $ mn 89
Figure 52. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe, 2019-2030, $ mn 91
Figure 53. Growth Stage of Europe Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period 93

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Europe Point of Care (PoC) Molecular Diagnostics Market 2020-2030

We are friendly and approachable, give us a call.